Exact Mass: 566.2574
Exact Mass Matches: 566.2574
Found 190 metabolites which its exact mass value is equals to given mass value 566.2574
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
PA(2:0/6 keto-PGF1alpha)
PA(2:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/6 keto-PGF1alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(6 keto-PGF1alpha/2:0)
PA(6 keto-PGF1alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/2:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/TXB2)
PA(2:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/TXB2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(TXB2/2:0)
PA(TXB2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/2:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
(1R,2S,4S,5S,6R,7S,8S,9R,10S)-1-acetoxy-9-benzoyloxy-8-trans-cinnamoyloxy-2,4,6-trihydroxydihydro-beta-agarofuran
(20S,22S,23S,24S,25S,26S)-5alpha-chloro-12alpha,22-23,26,24,25-triepoxy-12-ethoxy-6beta,17beta,26-trihydroxyergosta-2-en-1-one|12-O-ethyl-jaborosalactol 25|12-O-ethyljaborosalactol 25
Ala Gln Trp Tyr
Ala Gln Tyr Trp
Ala Trp Gln Tyr
Ala Trp Tyr Gln
Ala Tyr Gln Trp
Ala Tyr Trp Gln
Phe His Thr Tyr
Phe His Tyr Thr
Phe Met Asn Arg
Phe Met Arg Asn
Phe Asn Met Arg
Phe Asn Arg Met
Phe Asn Thr Trp
Phe Asn Trp Thr
Phe Gln Ser Trp
Phe Gln Trp Ser
Phe Arg Met Asn
Phe Arg Asn Met
Phe Ser Gln Trp
Phe Ser Trp Gln
Phe Thr His Tyr
Phe Thr Asn Trp
Phe Thr Trp Asn
Phe Thr Tyr His
Phe Trp Asn Thr
Phe Trp Gln Ser
Phe Trp Ser Gln
Phe Trp Thr Asn
Phe Tyr His Thr
Phe Tyr Thr His
His Phe Thr Tyr
His Phe Tyr Thr
His Pro Gln Trp
His Pro Trp Gln
His Gln Pro Trp
His Gln Trp Pro
His Thr Phe Tyr
His Thr Tyr Phe
His Trp Pro Gln
His Trp Gln Pro
His Tyr Phe Thr
His Tyr Thr Phe
Met Phe Asn Arg
Met Phe Arg Asn
Met Asn Phe Arg
Met Asn Arg Phe
Met Arg Phe Asn
Met Arg Asn Phe
Asn Phe Met Arg
Asn Phe Arg Met
Asn Phe Thr Trp
Asn Phe Trp Thr
Asn Met Phe Arg
Asn Met Arg Phe
Asn Arg Phe Met
Asn Arg Met Phe
Asn Thr Phe Trp
Asn Thr Trp Phe
Asn Trp Phe Thr
Asn Trp Thr Phe
Pro His Gln Trp
Pro His Trp Gln
Pro Gln His Trp
Pro Gln Trp His
Pro Trp His Gln
Pro Trp Gln His
Gln Ala Trp Tyr
Gln Ala Tyr Trp
Gln Phe Ser Trp
Gln Phe Trp Ser
Gln His Pro Trp
Gln His Trp Pro
Gln Pro His Trp
Gln Pro Trp His
Gln Ser Phe Trp
Gln Ser Trp Phe
Gln Trp Ala Tyr
Gln Trp Phe Ser
Gln Trp His Pro
Gln Trp Pro His
Gln Trp Ser Phe
Gln Trp Tyr Ala
Gln Tyr Ala Trp
Gln Tyr Trp Ala
Arg Phe Met Asn
Arg Phe Asn Met
Arg Met Phe Asn
Arg Met Asn Phe
Arg Asn Phe Met
Arg Asn Met Phe
Ser Phe Gln Trp
Ser Phe Trp Gln
Ser Gln Phe Trp
Ser Gln Trp Phe
Ser Trp Phe Gln
Ser Trp Gln Phe
Thr Phe His Tyr
Thr Phe Asn Trp
Thr Phe Trp Asn
Thr Phe Tyr His
Thr His Phe Tyr
Thr His Tyr Phe
Thr Asn Phe Trp
Thr Asn Trp Phe
Thr Trp Phe Asn
Thr Trp Asn Phe
Thr Tyr Phe His
Thr Tyr His Phe
Trp Ala Gln Tyr
Trp Ala Tyr Gln
Trp Phe Asn Thr
Trp Phe Gln Ser
Trp Phe Ser Gln
Trp Phe Thr Asn
Trp His Pro Gln
Trp His Gln Pro
Trp Asn Phe Thr
Trp Asn Thr Phe
Trp Pro His Gln
Trp Pro Gln His
Trp Gln Ala Tyr
Trp Gln Phe Ser
Trp Gln His Pro
Trp Gln Pro His
Trp Gln Ser Phe
Trp Gln Tyr Ala
Trp Ser Phe Gln
Trp Ser Gln Phe
Trp Thr Phe Asn
Trp Thr Asn Phe
Trp Tyr Ala Gln
Trp Tyr Gln Ala
Tyr Ala Gln Trp
Tyr Ala Trp Gln
Tyr Phe His Thr
Tyr Phe Thr His
Tyr His Phe Thr
Tyr His Thr Phe
Tyr Gln Ala Trp
Tyr Gln Trp Ala
Tyr Thr Phe His
Tyr Thr His Phe
Tyr Trp Ala Gln
Tyr Trp Gln Ala
Cyclopropyl-[5-[[4-[[4-(2-methoxyphenyl)-1-piperazinyl]-oxomethyl]-1-piperidinyl]sulfonyl]-2-methyl-2,3-dihydroindol-1-yl]methanone
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-2-carboxylatoethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoate
N-[(2R,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(3-propan-2-ylanilino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-cyanobenzamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-phenylmethanesulfonamide
[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
leukotriene F4(2-)
A leukotriene anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group of leukotriene F4; major species at pH 7.3.